Burn
2
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
MediWoundDGD
MediWoundDGD
AVITA MedicalCohealyx
Clinical Trials (3)
Total enrollment: 259 patients across 3 trials
Enzymatic Debridement in Burns Patients: A Comparison to Standard of Care
Start: Dec 2005Est. completion: Feb 2010182 patients
Phase 3Completed
Feasibility Study: Enzymatic Debridement in Patients With Partial Thickness Burns
Start: Dec 2009Est. completion: Dec 201536 patients
Phase 2Completed
Multicenter Single-arm Trial to Investigate Clinical Outcomes When Cohealyx™ is Used for Full Thickness Wounds
Start: May 2025Est. completion: Aug 202641 patients
N/AActive Not Recruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
2 companies competing in this space